Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 1151 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Existential Distress in Advanced Cancer: A Cohort Study
Rebecca Philipp, Charlotte Walbaum,Uwe Koch,Karin Oechsle, Thies Daniels, Friederike Helmich, Marlitt Horn, Johanna Junghans,David Kissane, Guntram Lock, Christopher Lo, Anne Mruk-Kahl,Volkmar Müller,Martin Reck,Georgia Schilling,Kornelius Schulze,Johann von Felden,Carsten Bokemeyer,Martin Härter,Sigrun Vehling
General hospital psychiatry (2025): 184-191
Cited0Views0WOSBibtex
0
0
A Plain Language Summary of Atezolizumab Compared with Single-Agent Chemotherapy in Participants with Non-Small Cell Lung Cancer Who Should Not Receive Platinum-Based Chemotherapy (the IPSOS Study)
Siow Ming Lee, Christian Schulz, Anne-Marie Baird,Kumar Prabhash, Dariusz Kowalski,Aleksandra Szczesna,Baohui Han,Achim Rittmeyer, Toby Talbot,David Vicente,Raffaele Califano,Diego Cortinovis,Anh Tuan Le,Dingzhi Huang,Geoffrey Liu,Federico Cappuzzo, Jessica Reyes Contreras,Martin Reck,Ramon Palmero, Milena Perez Mak, Youyou Hu, Stefanie Morris, Monika Kaul, Patricia Corey-Lisle, Barbara Gitlitz,Solange Peters
Future oncology (London, England)no. 14 (2025): 1725-1734
Cited0Views0WOSBibtex
0
0
Treatment-Free Survival over 6 Years of Follow-up in Patients with Metastatic Non-small Cell Lung Cancer Treated with First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1
Solange Peters,Meredith M Regan, Luis G Paz-Ares,Martin Reck,Hossein Borghaei, Kenneth J O'Byrne, Julie R Brahmer, John R Penrod, Janice Li, LaRee Tracy,Yong Yuan, Judith Bushong,Adam Lee, Laura J Eccles, Saurabh Ray, Suresh S Ramalingam
Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2025)
Cited0Views0WOSBibtex
0
0
Five-Year Survival Outcomes with Atezolizumab after Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer (impower010): an Open-Label, Randomized, Phase III Trial
Enriqueta Felip, Nasser Altorki,Caicun Zhou,Eric Vallières,Tibor Csoszi, Ihor O Vynnychenko, Oleksandr Goloborodko,Achim Rittmeyer,Martin Reck,Alex Martinez-Marti,Hirotsugu Kenmotsu, Yuh-Min Chen,Antonio Chella,Shunichi Sugawara, Chenqi Fu,Marcus Ballinger,Yu Deng,Minu K Srivastava,Elizabeth Bennett,Barbara J Gitlitz, Heather A Wakelee, IMpower01 Study Investigators
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2401681-JCO2401681, (2025)
Cited0Views0WOSBibtex
0
0
Efficacy and Safety of First-Line Maintenance Therapy with Lurbinectedin Plus Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (imforte): a Randomised, Multicentre, Open-Label, Phase 3 Trial
Luis Paz-Ares,Hossein Borghaei, Stephen V Liu,Solange Peters,Roy S Herbst, Katarzyna Stencel, Margarita Majem,Mehmet Ali Nahit Şendur,Grzegorz Czyżewicz, Reyes Bernabé Caro,Ki Hyeong Lee, Melissa L Johnson,Nuri Karadurmuş,Christian Grohé,Sofia Baka,Tibor Csőszi,Jin Seok Ahn,Raffaele Califano,Tsung-Ying Yang,Yasemin Kemal,Marcus Ballinger, Vaikunth Cuchelkar, Vilma Graupner, Ya-Chen Lin, Debasis Chakrabarti, Kamalnayan Bhatt, George Cai,Robert Iannone,Martin Reck, IMforte investigators
Lancet (London, England)no. 10495 (2025): 2129-2143
Cited0Views0WOSBibtex
0
0
Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy
Marcel Wiesweg, Ali Alaffas, Anna Rasokat, Felix Carl Saalfeld, Maximilian Rost, Christin Assmann, Franziska Herster, Moritz Hilbrandt,Frank Griesinger,Anna Kron, Julia Roeper, Franziska Glanemann, Cornelia Kropf-Sanchen,Martin Reck, Jonas Kulhavy,Albrecht Stenzinger,Jürgen Wolf,Martin Sebastian,Martin Schuler,Martin Wermke,Nikolaj Frost, Hans-Georg Kopp, Petros Christopoulos,Matthias Scheffler
Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 1151

#Citation: 87338

H-Index: 102

G-Index: 289

Sociability: 9

Diversity: 3

Activity: 364

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn